Asterasys
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Asterasys makes aesthetic medical devices that tighten and rejuvenate skin without surgery, supplying clinics and hospitals in South Korea and internationally.
Its flagship product, Liftera, uses high-intensity focused ultrasound, a technology that delivers targeted energy beneath the skin, and is designed to reduce treatment discomfort while improving results. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, the company earns the bulk of its revenue from the Liftera product line while expanding its portfolio with newly approved non-invasive radiofrequency devices.
Summary is AI-generated and may contain errors · figures from DART filings
New products have received approval from South Korea's MFDS, the national medical-device regulator, and are pursuing separate US FDA clearance to access international markets.
Asterasys in five facts
What does Asterasys do?
Asterasys makes aesthetic medical devices that tighten and rejuvenate skin without surgery, supplying clinics and hospitals in South Korea and internationally.
Where is Asterasys listed and in which sector?
Asterasys (Korean name: 아스테라시스) trades under KRX code 450950 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Asterasys?
Its market capitalisation was US$144.8M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Asterasys's latest annual revenue and operating profit?
For fiscal year 2025, Asterasys reported revenue of US$28.6M, operating profit of US$7.8M and net income of US$7M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 31.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.